Showing results (31-40 of 224) with videos related to
Sort By:
Pageof 23
Pediatric Blood & Cancer|December 1, 2020
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysisLenka A Ilcisin, Clement Ma, Katherine A Janeway, et al.Journal of the National Cancer Institute|March 7, 2015
Marketing of personalized cancer care on the web: an analysis of Internet websitesStacy W Gray, Angel Cronin, Elizabeth Bair, et al.Journal of Surgical Oncology|March 3, 2004
Solid and papillary epithelial neoplasm of the pancreasAtul K Madan, Christopher B Weldon, William P Long, et al.Journal of Pediatric Hematology/Oncology|December 17, 2019
PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate?Sonja Chen, Lillian M Guenther, Amanda Aronhalt, et al.Clinics in Perinatology|February 15, 2021
Neonatal Malignant Disorders: Germ Cell TumorsRachana Shah, Brent R Weil, Christopher B Weldon, et al.Journal of Pediatric Surgery|June 19, 2023
Lymphatic Embolization for the Management of Post-operative Chyle Leaks Following Solid Tumor Resection in Pediatric PatientsTrever M Koester, Rush H Chewning, Christopher B Weldon, et al.Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|November 19, 2015
Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or ResectionZareen Vadva, Marc R Laufer, Christopher B Weldon, et al.Cancer Chemotherapy and Pharmacology|April 22, 2019
Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trialArnauld C Verschuur, Viera Bajčiová, Leo Mascarenhas, et al.Journal of Pediatric Surgery|January 7, 2022
Complications associated with totally implantable access ports in children less than 1 year of ageAaron B Ross, Eva Rouanet, Andrew J Murphy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA SymposiumKristin M Wessel, Katherine A Janeway, Lara E Davis, et al.Pageof 23